Accelerate Diagnostics Inc [AXDX] stock is trading at $2.00, up 4.64%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The AXDX shares have gain 12.29% over the last week, with a monthly amount glided 50.28%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Accelerate Diagnostics Inc [NASDAQ: AXDX] stock has seen the most recent analyst activity on March 09, 2022, when Craig Hallum downgraded its rating to a Hold but kept the price target unchanged to $5 for it. On August 07, 2020, upgrade upgraded it’s rating to Buy but maintained its price target of $20 on the stock. JP Morgan downgraded its rating to a Underweight but stick to its price target of $16 on September 27, 2019. JP Morgan downgraded its rating to a Neutral. Craig Hallum started tracking with a Hold rating for this stock on May 24, 2018, and assigned it a price target of $25. In a note dated December 13, 2017, BTIG Research downgraded an Neutral rating on this stock.
Accelerate Diagnostics Inc [AXDX] stock has fluctuated between $0.73 and $7.25 over the past year. Accelerate Diagnostics Inc [NASDAQ: AXDX] shares were valued at $2.00 at the most recent close of the market.
Analyzing the AXDX fundamentals
Accelerate Diagnostics Inc [NASDAQ:AXDX] reported sales of 12.23M for the trailing twelve months, which represents a growth of 2.23%. Gross Profit Margin for this corporation currently stands at 0.17% with Operating Profit Margin at -3.43%, Pretax Profit Margin comes in at -3.05%, and Net Profit Margin reading is -3.11%. To continue investigating profitability, this company’s Return on Assets is posted at -1.66, Equity is 1.31 and Total Capital is -4.42. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -1.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.8392 points at the first support level, and at 1.6796 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.0991, and for the 2nd resistance point, it is at 2.1994.
Ratios To Look Out For
For context, Accelerate Diagnostics Inc’s Current Ratio is 1.28. Further, the Quick Ratio stands at 1.04, while the Cash Ratio is 0.64. Considering the valuation of this stock, the price to sales ratio is 3.87.
Transactions by insiders
Recent insider trading involved Mertz Larry Michael, Chief Technology Officer, that happened on May 20 ’24 when 361.0 shares were sold. Chief Executive Officer, Phillips Jack completed a deal on Apr 17 ’24 to sell 26735.0 shares. Meanwhile, Chief Executive Officer Phillips Jack sold 26545.0 shares on Apr 12 ’24.
